SAMPLES FOR CYTOLOGICAL DIAGNOSIS OF LUNG CANCER

Andrey А. Kireev – MD, PhD, Cytopathologist, Clinical Diagnostic Laboratory of the Yudin Clinical Hospital of the Moscow Health Department, Moscow, Russia; Russian Medical Academy of Continuing Professional Education of the Russian Ministry of Health, Moscow, Russia. E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.
Konstantin V. Shchetinin – MD, Oncologist, Deputy Chief Physician for Organizational and Methodological Work of the Orenburg Regional Clinical Oncological Dispensary, Orenburg, Russia. E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.

1. Laktionov KK, Artamonova EV, Borisova TN, et al. Malignant neoplasm of the bronchi and lung: Russian clinical guidelines. Sovremennaya Onkologiya. 2021;23(3):369-402 (In Russ.). DOI: 10.26442/18151434.2021.3.201048
2. Kaprin AD, Starinsky VV, Shakhzadova AO, editors. Malignant neoplasms in Russia in 2021 (morbidity and mortality). M.: MNIOI im. P.A. Gercena ? filial FGBU ?NMIC radiologiI? Minzdrava Rossii; 2022. Fig. 252 p. (In Russ.). ISBN 978-5-85502-280-3.
3. Grigoruk OG, Pupkova EI, Bazulina LM, Lazarev AF. The usage of cytological material for diagnostics of lung cancer. Zlokachestvennye opukholi. 2017;4:13-20. (In Russ.). DOI: 10.18027/2224-5057-2017-7-4-13-20
4. Sareen R, Pandey CL. Lung malignancy: Diagnostic accuracies of bronchoalveolar lavage, bronchial brushing, and fine needle aspiration cytology. Lung India. 2016;33(6):635-41. DOI: 10.4103/0970-2113.192882
5. Martirosova KM, Zhandarova LF, Matveyeva OV. Рossibilities of cytological research method in the diagnosis of lung tumors. Medicus. 2020;4(34):32-40. (In Russ.).
6. Savostikova MV, Furmanskaya EYu, Eleubaeva ZhB. Modern approach in cytological diagnosis of lung tumors. Onkologiya i radiologiya Kazakhstana. 2017;3(45):18-24. (In Russ.).
7. Savostikova, MV, Fedoseeva ES, Furminskaya EY. Modern cytomorphological diagnosis of lung tumors. Novosti klinicheskoj citologii Rossii. 2018;22(3-4):3-7. (In Russ.).
8. Chen CC, Bai CH, Lee KY, et al. Evaluation of the diagnostic accuracy of bronchial brushing cytology in lung cancer: A meta-analysis. Cancer Cytopathol. 2021;129(9):739-49. DOI: 10.1002/cncy.22436
9. Nicholson AG, Tsao MS, Beasley MB, et al. The 2021 WHO classification of lung tumors: Impact of advances since 2015. J Thorac Oncol. 2022;17(3):362-87. DOI: 10.1016/j.jtho.2021.11.003
10. Fassunke J, Engels M, Meemboor S, Buettner R. Zytopathologie und molekulare Diagnostik von nichtkleinzelligen Lungenkarzinomen (NSCLC) [Cytopathology and molecular diagnostics of non-small cell lung cancer (NSCLC)]. Inn Med (Heidelb). 2022;63(7):694-9. German. DOI: 10.1007/s00108-022-01365-1
11. Layfield LJ, Esebua M. A modified Papanicolaou Society of Cytopathology system for reporting respiratory cytology specimens: Implications for estimates of malignancy risk and diagnostic accuracy. Diagn Cytopathol. 2021;49(11):1167-72. DOI: 10.1002/dc.24840
12. Johnston WW, Elson CE. Respiratory tract. In: Bibbo M, editor. Comprehensive cytopathology. 2nd ed. Philadelphia: W.B. Saunders Company; 1997.
13. McLean AEB, Barnes DJ, Troy LK. Diagnosing Lung Cancer: The Complexities of Obtaining a Tissue Diagnosis in the Era of Minimally Invasive and Personalised Medicine. J Clin Med. 2018;7(7):163. DOI: 10.3390/jcm7070163
14. Arsenyev AI, Nefedova AV, Ganeev AA., et al. Combined early diagnosis of lung cancer by determining the composition of exhaled air by non-selective methods of analysis of volatile organic compounds using metal oxide sensors with cross-sensitivity and cytological examination of sputum. Voprosy onkologii. 2020;66(4):381-4. (In Russ.).
15. Schreiber G, McCrory DC. Performance characteristics of different modalities for diagnosis of suspected lung cancer: summary of published evidence. Chest. 2003;123(1 Suppl):115S-128S. DOI: 10.1378/chest.123.1_suppl.115s
16. Tomar V, Vijay N, Nuwal P, Dixit R. Comparative study of bronchoalveolar lavage, bronchial brushing, and FNAC in diagnosing malignant neoplasms of lungs. J Cytol. 2016;33(4):210-3. DOI: 10.4103/0970-9371.190448
17. Denley H, Singh N, Clelland CA. Transthoracic fine needle aspiration cytology of lung for suspected malignancy: an audit of cytological findings with histopathological correlation. Cytopathology. 1997;8(4):223-9. DOI: 10.1046/j.1365-2303.1997.5482054.x
18. Ali MS, Trick W, Mba BI, et al. Radial endobronchial ultrasound for the diagnosis of peripheral pulmonary lesions: A systematic review and meta-analysis. Respirology. 2017;22(3):443-53. DOI: 10.1111/resp.12980
19. Maghfoor I, Perry MC. Lung cancer. Ann Saudi Med. 2005;25(1):1-12. DOI: 10.5144/0256-4947.2005.1
20. Strunina AA. Sokolov DV, Sokolov VV, Volchenko NN, Kashin SV. Modern approaches to the diagnosis of precancerous pathology and early lung cancer. Khirurgiya. Zurnal im. N.I. Pirogova. 2018;(3):27-32. (In Russ.). DOI: 10.17116/hirurgia20183227-32
21. Maghfoor I, Perry MC. Lung cancer. Ann Saudi Med. 2005;25(1):1-12. DOI: 10.5144/0256-4947.2005.1
22. Berlin NI. Overview of the NCI cooperative early lung cancer detection program. Cancer. 2000;89(11 Suppl):2349-51. DOI: 10.1002/1097-0142(20001201)89:11+<2349::aid-cncr6>3.3.co;2-w
23. Fontana RS, Sanderson DR, Taylor WF, et al. Early lung cancer detection: results of the initial (prevalence) radiologic and cytologic screening in the Mayo Clinic study. Am Rev Respir Dis. 1984;130(4):561-5. DOI: 10.1164/arrd.1984.130.4.561
24. Frost JK, Ball WC Jr, Levin ML, et al. Early lung cancer detection: results of the initial (prevalence) radiologic and cytologic screening in the Johns Hopkins study. Am Rev Respir Dis. 1984;130(4):549-54. DOI: 10.1164/arrd.1984.130.4.549
25. Doria-Rose VP, Marcus PM, Szabo E, Tockman MS, Melamed MR, Prorok PC. Randomized controlled trials of the efficacy of lung cancer screening by sputum cytology revisited: a combined mortality analysis from the Johns Hopkins Lung Project and the Memorial Sloan-Kettering Lung Study. Cancer. 2009;115(21):5007-17. DOI: 10.1002/cncr.24545
26. Manser RL, Irving LB, Byrnes G, Abramson MJ, Stone CA, Campbell DA. Screening for lung cancer: a systematic review and meta-analysis of controlled trials. Thorax. 2003;58(9):784-9. DOI: 10.1136/thorax.58.9.784
27. Flehinger BJ, Melamed MR, Zaman MB, Heelan RT, Perchick WB, Martini N. Early lung cancer detection: results of the initial (prevalence) radiologic and cytologic screening in the Memorial Sloan-Kettering study. Am Rev Respir Dis. 1984;130(4):555-60. DOI: 10.1164/arrd.1984.130.4.555
28. Petty TL. Sputum cytology for the detection of early lung cancer. Curr Opin Pulm Med. 2003;9(4):309-12. DOI: 10.1097/00063198-200307000-00011
29. Neumann T, Meyer M, Patten FW, et al. Premalignant and malignant cells in sputum from lung cancer patients. Cancer. 2009;117(6):473-81. DOI: 10.1002/cncy.20052
30. Schreiber G, McCrory DC. Performance characteristics of different modalities for diagnosis of suspected lung cancer: summary of published evidence. Chest. 2003;123(1 Suppl):115S-128S. DOI: 10.1378/chest.123.1_suppl.115s
31. Schreiber G, McCrory DC. Performance characteristics of different modalities for diagnosis of suspected lung cancer: summary of published evidence. Chest. 2003;123(1 Suppl):115S-128S. DOI: 10.1378/chest.123.1_suppl.115s
32. Roby TJ, Swan GE, Sorensen KW, Hubbard GA, Schumann GB. Discriminant analysis of lower respiratory tract components associated with cigarette smoking, based on quantitative sputum cytology. Acta Cytol. 1990;34(2):147-54.
33. Mehta AC, Marty JJ, Lee FY. Sputum cytology. Clin Chest Med. 1993;14(1):69-85.
34. Schumann GB, Roby TJ, Swan GE, Sorensen KW. Quantitative sputum cytologic findings in 109 nonsmokers. Am Rev Respir Dis. 1989;139(3):601-3. DOI: 10.1164/ajrccm/139.3.601
35. Kennedy TC, Proudfoot SP, Franklin WA, et al. Cytopathological analysis of sputum in patients with airflow obstruction and significant smoking histories. Cancer Res. 1996;56(20):4673-8.
36. Breuer RH, Pasic A, Smit EF, et al. The natural course of preneoplastic lesions in bronchial epithelium. Clin Cancer Res. 2005;11(2 Pt 1):537-43.
37. Kennedy TC, Franklin WA, Prindiville SA, et al. High prevalence of occult endobronchial malignancy in high risk patients with moderate sputum atypia. Lung Cancer. 2005;49(2):187-91. DOI: 10.1016/j.lungcan.2005.02.009
38. Byers T, Wolf HJ, Franklin WA, et al. Sputum cytologic atypia predicts incident lung cancer: defining latency and histologic specificity. Cancer Epidemiol Biomarkers Prev. 2008;17(1):158-62. DOI: 10.1158/1055-9965.EPI-07-0436
39. Hogea SP, Tudorache E, Pescaru C, Marc M, Oancea C. Bronchoalveolar lavage: role in the evaluation of pulmonary interstitial disease. Expert Rev Respir Med. 2020;14(11):1117-30. DOI: 10.1080/17476348.2020.1806063
40. Meyer KC. Bronchoalveolar lavage as a diagnostic tool. Semin Respir Crit Care Med. 2007;28(5):546-60. DOI: 10.1055/s-2007-991527
41. Meyer KC, Raghu G. Bronchoalveolar lavage for the evaluation of interstitial lung disease: is it clinically useful?. Eur Respir J. 2011;38(4):761-9. DOI: 10.1183/09031936.00069509
42. Rao S, Rao S, Lal A, Barathi G, Dhanasekar T, Duvuru P. Bronchial wash cytology: A study on morphology and morphometry. J Cytol. 2014;31(2):63-7. DOI: 10.4103/0970-9371.138664
43. Domagala-Kulawik J. The relevance of bronchoalveolar lavage fluid analysis for lung cancer patients. Expert Rev Respir Med. 2020;14(3):329-37. DOI: 10.1080/17476348.2020.1708720
44. Truong LD, Underwood RD, Greenberg SD, McLarty JW. Diagnosis and typing of lung carcinomas by cytopathologic methods. A review of 108 cases. Acta Cytol. 1985;29(3):379-84.
45. Gray W, editor. Diagnostic cytopathology. 3rd ed. China: Elsevier’s Health Sciences; 2010: 930.
46. Zavala DC, Richardson RH, Mukerjee PK, Rossi NP, Bedell GN. Use of the bronchofiberscope for bronchial brush biopsy. Diagnostic results and comparison with other brushing techniques. Chest. 1973;63(6):889-92. DOI: 10.1378/chest.63.6.889
47. Tomar V, Vijay N, Nuwal P, Dixit R. Comparative study of bronchoalveolar lavage, bronchial brushing, and FNAC in diagnosing malignant neoplasms of lungs. J Cytol. 2016;33(4):210-3. DOI: 10.4103/0970-9371.190448
48. Gaur DS, Thapliyal NC, Kishore S, Pathak VP. Efficacy of broncho-alveolar lavage and bronchial brush cytology in diagnosing lung cancers. J Cytol. 2007;24:73-7.
49. Liam CK, Pang YK, Poosparajah S. Diagnostic yield of flexible bronchoscopic procedures in lung cancer patients according to tumour location. Singapore Med J. 2007;48(7):625-31.
50. Karahalli E, Yilmaz A, T?rker H, Ozvaran K. Usefulness of various diagnostic techniques during fiberoptic bronchoscopy for endoscopically visible lung cancer: should cytologic examinations be performed routinely? Respiration. 2001;68(6):611-4. DOI: 10.1159/000050581
51. Reynolds JP, Voss JS, Brankley SM, et al. Diagnostic accuracy of bronchial brush cytology and the added value of immunohistochemistry and fluorescence in situ hybridization of pulmonary neuroendocrine tumors. Cytojournal. 2014;11:32. DOI: 10.4103/1742-6413.146120
52. Zakowski MF. Cytology nomenclature and 2015 World Health Organization classification of lung cancer. Cancer Cytopathol. 2016;124(2):81-8. DOI: 10.1002/cncy.21628
53. Layfield LJ, Pearson L, Walker BS, White SK, Schmidt RL. Diagnostic accuracy of fine-needle aspiration cytology for discrimination of squamous cell carcinoma from adenocar-cinoma in non-small cell lung cancer: A systematic review and meta-analysis. Acta Cytol. 2018;62(5-6):318-26. DOI: 10.1159/000493942
54. Saad RS, Silverman JF. Respiratory cytology: differential diagnosis and pitfalls. Diagn Cytopathol. 2010;38(4):297-307. DOI: 10.1002/dc.21205
55. Saha A, Kumar K, Choudhuri MK. Computed tomography-guided fine needle aspiration cytology of thoracic mass lesions: A study of 57 cases. J Cytol. 2009;26(2):55-9. DOI: 10.4103/0970-9371.55222
56. Jindal SK. Pulmonary Neoplasms. In: JN Pande, editor. Respiratory medicine in the tropics, 1st ed. Delhi: Oxford University press; 1998. p. 439-50.
57. Larscheid RC, Thorpe PE, Scott WJ. Percutaneous trans-thoracic needle aspiration biopsy: a comprehensive review of its current role in the diagnosis and treatment of lung tumors. Chest. 1998;114(3):704-9. DOI: 10.1378/chest.114.3.704
58. Chraba?ska M, ?roda M, Kiczmer P, Drozdzowska B. Lung cancer cytology: can any of the cytological methods replace histopathology? J Cytol. 2020;37(3):117-21. DOI: 10.4103/JOC.JOC_168_19
59. Yang MC, Liu WT, Wang CH, et al. Diagnostic value of endobronchial ultrasound-guided transbronchial lung biopsy in peripheral lung cancers. J Formos Med Assoc. 2004;103(2):124-9.
60. Chao TY, Chien MT, Lie CH, Chung YH, Wang JL, Lin MC. Endobronchial ultrasonography-guided transbronchial needle aspiration increases the diagnostic yield of peripheral pul-monary lesions: a randomized trial. Chest. 2009;136(1):229-36. DOI: 10.1378/chest.08-0577
61. Wang JF, Baidoo C, Collins BT. Improved efficacy of endobronchial ultrasound-guided fine-needle aspiration biopsy in comparison to endobronchial ultrasound-guided miniforceps biopsy. Acta Cytol. 2014;58(2):125-30. DOI: 10.1159/000357358
62. Crapanzano JP, Saqi A. Pitfalls in pulmonary cytopathology. Diagn Cytopathol. 2011;39(2):144-54. DOI: 10.1002/dc.21396
63. Sareen R, Pandey CL. Lung malignancy: Diagnostic accuracies of bronchoalveolar lavage, bronchial brushing, and fine needle aspiration cytology. Lung India. 2016;33(6):635-41. DOI: 10.4103/0970-2113.192882
64. Rohtagi S, Khan L, Pantola C, Kumar A, Singh PK. Correlationof fine needle aspiration cytology with bronchoalveolar lavage and brush smear cytology in pulmonary lesions. J Evol Med Dent Sci 2014;3:6957-64.
65. Volchenko NN, Borisova OV, Melnikova VYu, Ermolaeva AG, Glukhova YuK, Slavnova EN. Urgent morphological diagnosis in oncology. Onkologiya. Zhurnal im. P.A. Gertsena. 2020;9(1):5-13. (In Russ.). DOI: 10.17116/onkolog202090115
66. Sugiyama T, Tajiri T, Fujita H, et al. Diagnostic utility and pitfalls of intraoperative pulmonary imprint cytology based on final pathological diagnoses. Cytopathology. 2019;30(1):74-81. DOI: 10.1111/cyt.12649
67. Yuan M, Wang Y, Yin W, Xiao Y, Hu M, Hu Y. Efficacy of rapid on-site cytological evaluation (ROSE) by a pulmonologist in determining specimen adequacy and diagnostic accuracy in inter-ventional diagnosis of lung lesions. J Int Med Res. 2021;49(2):300060520982687. DOI: 10.1177/0300060520982687
68. Wang H, Wei N, Tang Y, et al. The utility of rapid on-site evaluation during bronchoscopic biopsy: A 2-year respiratory endoscopy central experience. Biomed Res Int. 2019;2019:5049248. DOI: 10.1155/2019/5049248
69. Jain D, Allen TC, Aisner DL, et al. Rapid on-site evaluation of endobronchial ultrasound-guided transbronchial needle aspirations for the diagnosis of lung cancer: A perspective from members of the pulmonary pathology society. Arch Pathol Lab Med. 2018;142(2):253-62. DOI: 10.5858/arpa.2017-0114-SA
70. Pisapia P, Malapelle U, Troncone G. Liquid biopsy and lung cancer. Acta cytologica. 2019;63(6):489-96. DOI: 10.1159/000492710